Expression of IR21a, IR93a, and IR25a proteins decreases in DOCCs at the late third instar. by Jordan J. Tyrrell (10535989)

Decreased mitochondrial respiratory function in GWI. by Joel N. Meyer (249728)

Subjects:

Third. by Cuicui Liu (1496260)

Details of hyperparameters used the secondond and third experiments. by Rovin Tiwari (22258480)

Subjects:

Cancer drugs that decrease cardiomyocyte viability induce cellular stress. by E. Renee Matthews (18071587)

Demonstration of decreased Aβ accumulation by DA-9601 treatment. by Mijung Lee (397790)

Odds ratios for confirmed markers of transfusion-transmitted infectious diseases in blood and its component donations in Lithuania: A comparison between pandemic years. by Vytenis Kalibatas (14123877)

Subjects:

Distribution of miRs with a greater than two fold-change. by Stephanie L. Samani (17896610)

Decrease in total fluorescence can be used as a proxy for loss of cell viability. by Robin Green (732789)

Shared and exclusive Amplicon Sequence Variants (ASVs) between the postpartum weeks (first, third, and fourth week). by Pedro A. R. Vanzele (17655589)

Higher reward decreases three measures of response variability. by Zvi N. Roth (9611598)

Decreased GSH/GSSG redox balance in glaucoma monocytes. by Takeshi Yabana (8201211)

Decreased pH is necessary and sufficient for intestinal hyperinflammation. by M. Kristina Hamilton (9162785)

HFD induces LDs and decreases ER and mitochondria in nephrocytes. by Aleksandra Lubojemska (10746241)

“…(<b>E</b>) Low and high magnification views of pericardial nephrocytes (dotted outlines) from STD and HFD larvae, showing that HFD decreases mitochondria (marked with anti-ATP5A) and ER (marked with anti-KDEL) but increases LDs (marked with LipidTOX). …”

Neutralization potency decreases 6-months post 2^nd vaccine but breadth and potency increase after a 3^rd vaccine dose. by Carl Graham (9415779)

Validation of child labor measures using third-party data, households with all children in school. by Guilherme Lichand (11410286)

Search duration decreases with target value and increases with the environment’s probability of containing a reward target. by Michael R. Traner (11836571)

Table_1_Previous Use of Anti-Vascular Endothelial Growth Factor Receptor Agents Decreases Efficacy of Fruquintinib in Metastatic Colorectal Cancer Refractory to Standard Therapies.... by Lei Wang (6656)

“…</p>Conclusion<p>Fruquintinib was an effective third-line therapy in mCRC with tolerable AEs. Efficacy of fruquintinib was decreased in patients with previous use of anti-VEGFR agents. …”

tRNA genes with greater than two-fold change in 3’ end reads up on AZM treatment. by Salini Konikkat (11114137)

Fig 2 - by Dongmin Kim (6237977)

Subjects: